NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Medtronic SYMBIOSIS Post-Market Registry for Patients Undergoing Cardiac Surgery

RecruitingN/A

Sponsor: Medtronic Cardiac Surgery

Conditions: Cardiovascular Diseases

Countries: Austria, Belgium, France, Germany, Greece, Netherlands, Norway, Spain

The purpose of this observational, multi-center prospective, post-market registry is to confirm real-world device safety and performance, to ensure the continued acceptability of identified risks, and detect emerging risks.

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Subject or legally authorized representative provides written data release and/or informed consent per institution and/or geographical requirements prior to discharge from participating registry hospital.
* Subject will undergo or underwent a procedure in which an eligible Medtronic CS product is/was used.

Exclusion Criteria:

* Currently participating in an interventional drug or device study which may induce confounding factor(s) to the results from this Registry

Locations (14)

Vienna, Austria
Genk, Belgium
Leuven, Belgium
Angers, France
Metz, France
Aachen, Germany
Bad Oeynhausen, Germany
Munich, Germany
Athens, Greece
Eindhoven, Netherlands
Maastricht, Netherlands
Nieuwegein, Netherlands
Bergen, Norway
Barcelona, Spain